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Rapid identification of microbial pathogens reduces infection-related morbidity and mortality of hospital-
ized patients. Raman spectra and Fourier transform infrared (IR) spectra constitute highly specific spectro-
scopic fingerprints of microorganisms by which they can be identified. Little biomass is required, so that
spectra of microcolonies can be obtained. A prospective clinical study was carried out in which the causative
pathogens of bloodstream infections in hospitalized patients were identified. Reference libraries of Raman and
IR spectra of bacterial and yeast pathogens highly prevalent in bloodstream infections were created. They were
used to develop identification models based on linear discriminant analysis and artificial neural networks.
These models were tested by carrying out vibrational spectroscopic identification in parallel with routine
diagnostic phenotypic identification. Whereas routine identification has a typical turnaround time of 1 to 2
days, Raman and IR spectra of microcolonies were collected 6 to 8 h after microbial growth was detected by
an automated blood culture system. One hundred fifteen samples were analyzed by Raman spectroscopy, of
which 109 contained bacteria and 6 contained yeasts. One hundred twenty-one samples were analyzed by IR
spectroscopy. Of these, 114 yielded bacteria and 7 were positive for yeasts. High identification accuracy was
achieved in both the Raman (92.2%, 106 of 115) and IR (98.3%, 119 of 121) studies. Vibrational spectroscopic
techniques enable simple, rapid, and accurate microbial identification. These advantages can be easily trans-
ferred to other applications in diagnostic microbiology, e.g., to accelerate identification of fastidious
microorganisms.
The time required for the identification of pathogens is an
important determinant of infection-related mortality rates of
hospitalized patients. Rapid identification techniques signifi-
cantly reduce mortality and costs associated with infectious
diseases (3). Most commercially available identification sys-
tems in routine use in hospitals are based on the physiological
and nutritional characteristics of microorganisms. These sys-
tems require a pure microbial culture and a large inoculum
(13). Consequently, a turnaround time of 24 h (e.g., for Staph-
ylococcus aureus) to up to 5 days (for Candida species) between
receipt of patient material and presentation of identification
results to the clinician is common. Therefore, empirical treat-
ment with broad-spectrum antibiotics is often started while
awaiting further identification of the pathogens. It has been
reported that, as a result of this, 10 to 30% of patients suffering
from bloodstream infections in intensive care units (ICUs) do
not initially receive the correct antimicrobial therapy (9, 23).
Mortality rates in this group have been reported to be 30 to
60% higher than in the group that promptly receives appro-
priate therapy (6, 9). Apart from the risk that the empirical
treatment may not be effective at all, this practice may lead to
adverse toxic side effects (21) and is known to aggravate prob-
lems with resistance to antimicrobial agents (7). Early identi-
fication enables the clinician to precisely target a pathogen
with the most effective antimicrobial agent.
Novel genotypic approaches to the rapid identification of
clinically relevant microorganisms are finding their way into
the field of clinical diagnostic microbiology (17, 19). For ex-
ample, amplification of specific gene sequences by PCR assay
enables very sensitive methods to be developed (17). Further-
more, microbes can be detected and identified in complex
matrices by using fluorescence in situ hybridization targeting
the conserved 16S rRNA (1).
A radically different approach to the development of iden-
tification methods is based on spectroscopic techniques (4, 14,
15). These techniques are characterized by a minimum of sam-
ple handling: no extractions, amplifications, labeling, or stain-
ing steps of any kind are required. We have developed Raman
and Fourier transform (FT)-infrared (IR) spectroscopic tech-
niques for the rapid and accurate identification of clinically
relevant microorganisms. Vibrational spectra reflect the over-
all molecular composition of a sample. Since different organ-
isms differ in overall molecular composition, their Raman and
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FT-IR spectra will also be different (Fig. 1). The spectra can
serve as spectroscopic fingerprints that enable highly accurate
identification of microorganisms (14). Enterococcus species,
such as Enterococcus hirae, E. durans, and the vancomycin-
resistant species E. casseliflavus and E. gallinarum, were cor-
rectly identified by both FT-IR and Raman spectroscopy, while
most of the routinely used identification systems perform
poorly (8). Moreover, only a very small inoculum is required to
obtain spectra. Within 6 to 8 h after starting a culture on a
standard solid culture medium, most commonly encountered
pathogens develop microcolonies that are 10 to 100 m in
diameter from which reproducible Raman and FT-IR spectra
can be obtained. By Raman spectroscopy, spectra can be col-
lected directly from microcolonies on solid culture medium.
Confocal signal detection (18) is used to adapt the measure-
ment volume to the thin microcolonies, thereby minimizing
signal contributions from the culture medium. A specially de-
signed subtraction algorithm corrects for remaining signal con-
tributions from the culture medium (11). FT-IR spectra can be
collected from imprints of microcolonies on an IR-transparent
substrate (14). Microcolonies are transferred from the solid
culture medium to the substrate with a special stamping device
(15a), and then the imprint is allowed to dry.
In order to optimize the spectroscopic contrast between
different microorganisms, other sources of variation in molec-
ular composition must be minimized. This requires standard-
ization of culturing conditions, in particular, the culture me-
dium, incubation temperature, and culturing time. Culturing
time is important because microbial colonies growing on a
solid culture plate become increasingly heterogeneous with
respect to molecular composition. Such heterogeneity is absent
in small microcolonies obtained after 6 to 8 h of culturing (2).
Standardization of culturing conditions and instrument pa-
rameters enables the creation of reference libraries of micro-
organism spectra. Such libraries are the foundation of micro-
organism identification algorithms based, for example, on
linear discriminant analysis (LDA) (10) or on artificial neural
networks (ANNs) (22). These enable the identification of an
unknown microorganism on the basis of its Raman or FT-IR
spectrum. Here we present results of the first prospective clin-
ical study in which the causative pathogens of blood infections
were identified by vibrational spectroscopic methods.
MATERIALS AND METHODS
Sample preparation. For Raman spectroscopy, the reference strains were
seeded at 103 CFU/ml in 10-ml blood samples from healthy volunteers.
Aerobic culture vials (bacteria) or mycosis culture vials (yeasts) of the auto-
mated BACTEC 9240 blood culture system (Becton Dickinson, Cockeysville,
Md.) were inoculated with these samples. When the culture vials were flagged
as positive by the system, 100 l of the liquid culture medium was plated on
Mueller-Hinton medium (Merck, Darmstadt, Germany), which supports the
growth of a wide range of bacteria, or Sabouraud medium plus 2% glucose
(Merck) for yeasts. These cultures were incubated for 6 h at 37 or 30°C,
respectively, prior to Raman spectroscopy of microcolonies. Patient blood
samples that were positive according to the BACTEC system were treated in
the manner described above.
For IR measurements of reference strains, three calibrated platinum loops (1
mm in diameter) of biomass from an overnight culture were suspended in 10 ml
of prewarmed Luria broth (pancreatic digest of casein, NaCl, yeast extract;
Merck). The suspensions were diluted 100-fold for yeasts and 1,000-fold for
bacteria, and an aliquot of 100 l of this dilution was spread onto prewarmed
CASO agar plates (Merck) (bacteria) or Sabouraud agar plates plus 2% glucose
(Merck) (yeasts). Positive patient samples from the BacT/Alert system (Organon
Teknika, Eppelheim, Germany) were diluted 100-fold in Luria broth in order to
remove the charcoal particles from the culture medium. Two aliquots of 100 l
were than spread on CASO medium and Sabouraud medium plus 2% glucose,
respectively. After incubation for 6 to 8 h at 37°C, the microcolonies were
transferred from the agar plate onto a ZnSe substrate with a specially designed
stamping device (Ngo Thi et al., Biomed. Spectrosc.: Vib. Spectrosc. Other Novel
Tech., Proc. Soc. Prof. Ind. Eng.). After drying in air for 15 min, the microbial
spots deposited onto the IR-transparent plate were measured.
Phenotypic identification. Microbial identification in routine clinical diagnos-
tic laboratories was performed by phenotypic identification with the API and
Vitek systems (both from bioMe´rieux, Marcy-l’Etoile, France).
Confocal Raman microspectroscopy. Raman spectroscopic measurements
were performed as previously described (10, 11). Briefly, the solid culture me-
dium with microcolonies was placed directly under the microscope of a System
1000 Raman microspectrometer (Renishaw plc, Wotton-under-Edge, United
Kingdom). An 80 near-IR objective (MIR Plan 80/0.75; Olympus) was used
to focus 100 to 150 mW of laser light (830 nm) on the sample and collect
scattered light from the sample. Five microcolonies per plate were selected.
Within each microcolony, spectra were obtained from 10 randomly chosen lo-
cations with a signal collection time of 30 s per measurement. For each sample
measured, the 50 spectra thus obtained were averaged.
FT-IR microspectroscopy. FT-IR spectra were recorded on an FT-IR micro-
scope (IR Scope II interfaced with an IFS 28/B spectrometer; Bruker Optics,
Karlsruhe, Germany), equipped with a motorized x-y stage, a 15 Cassegrain
objective, and a broadband mercury cadmium telluride detector (12). All spectra
were acquired over 256 scans, and 10 microcolonies per imprint were measured,
resulting in a total measurement time of 18 min per sample.
Analysis of data. Analysis of data was performed as described before (8, 10, 11;
Opus I. R. Handbook, Bruker Optics). Reduction of data was performed by
principal-component analysis. The maximum number of n  1 principal compo-
nents was calculated (n is the number of spectra in the analysis), typically
accounting for 99 to 100% of the variation in the set of data. The reduced data
FIG. 1. Typical Raman (a) and FT-IR (b) spectra of four microor-
ganisms included in the reference database used for the identification
of pathogens isolated from blood. The spectra have been displaced
vertically on the intensity axis. Some marked spectral differences be-
tween the species have been highlighted. a.u., arbitrary units.
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served as the input for a hierarchical cluster analysis (HCA), an LDA, and an
ANN analysis. HCA is a means of objectively analyzing groups in a set of data on
the basis of spectral similarities. LDA and ANN analysis are both techniques by
which to classify unknown samples into predetermined groups. On the basis of
HCA groupings, LDA and ANN analysis models were constructed for species
identification (see below).
Reference databases of microorganism spectra and development of microor-
ganism identification models. Separate databases of reference Raman and
FT-IR spectra were created representing approximately 85% of the microbial
species most commonly encountered in blood infections of patients treated in the
ICUs of the University Hospital Rotterdam and the Rudolf Virchow Hospital
(Berlin, Germany) (see Table 1). The strains included in the reference databases
were either well-characterized clinical isolates or were obtained from culture
collections.
For Raman identification of bacteria, we used an approach similar to that
described previously for the identification of Candida species (10). Briefly, HCA
of the spectra in the reference library was used as a nonsubjective method by
which to determine the major groupings in the set of data. These groupings were
used as the starting point for the development of an identification tree based on
LDA (Fig. 2a). An LDA model was developed for each division in the tree.
Identification of a microorganism occurs by entering its spectrum into this iden-
tification tree at level 1. Depending on the outcome, it proceeds to one of the
models at level 2, etc. Likewise, a multilayered ANN analysis (Fig. 2b), consisting
of one top-level net and several subsequent subnets, was developed for identi-
fication based on IR spectra.
Analysis of clinical samples. Over a 4-month period, all consecutive positive
blood cultures from patients in the ICUs and a random selection of positive
blood cultures from patients in other wards of the University Hospital Rotter-
dam were used to test the Raman spectroscopic identification method. Similarly,
all positive blood cultures from the ICUs of the Rudolf Virchow Hospital were
collected over a 3-month period to test the FT-IR microspectroscopic identifi-
cation approach.
After the period of incubation on solid culture medium, cell morphology was
inspected by direct microscopy to distinguish bacteria from yeasts. On the basis
of this distinction, vibrational spectra were collected from isolates on the culture
medium that best supported the growth of that organism, e.g., Mueller-Hinton or
CASO medium for bacteria and Sabouraud medium plus 2% glucose for yeasts.
Raman and IR spectra thus obtained from patient samples were entered into the
respective identification trees for species identification as described above (Fig. 2).
When a strain was identified by the routine methods as a member of a genus
not included in the reference spectral databases, it was excluded from the com-
parison between routine identification methods and vibrational spectroscopic
identification.
RESULTS
Reference databases of microorganism spectra and devel-
opment of microorganism identification models. The database
of Raman spectra contained the spectra of 106 individual bac-
terial strains and 34 yeast strains (Table 1). In the IR database,
121 spectra were included (89 from bacterial strains and 32
from yeast strains). Marked spectral differences can be ob-
served in the Raman and IR spectra of different microbial
species. Some of the spectral regions in which the species differ
are shaded in Fig. 1. Although the spectra of different micro-
organisms could be analyzed in terms of their biochemical
differences, the analysis of large sets of data would become
very complicated. Interpreting the spectra as fingerprints and
using pattern recognition methods allows the development of
automated identification models.
Separate identification models were developed on the basis
of the Raman and IR databases. A first validation of the LDA
and ANN analysis models was performed by a leave-one-out
method (20) in which the spectra of all but one of the reference
strains were used to generate the respective models. The strain
that was left out was identified on the basis of its spectrum in
order to test the prediction models. This procedure was re-
peated for each strain. The results in Table 1 show that, at the
genus level, the models resulted in nearly perfect identification
with both databases. In the Raman database, the exceptions
were one Streptococcus strain that was identified as E. faecalis
and one Escherichia coli strain that was identified as E. cloacae.
Misidentifications also occurred in the IR database for two
Streptococcus strains that were identified as E. faecalis. At the
species level, the models performed nearly as well, with one
coagulase-negative Staphylococcus (CNS) strain being misclas-
sified as S. aureus in both the Raman and IR databases. Only
the separation of E. aerogenes and E. cloacae at level 5 of the
Raman identification proved more problematic, with 80.0%
correct identification in the leave-one-out evaluation. For the
TABLE 1. Results of leave-one-out evaluation of the Raman and infrared prediction models on the basis of strains
in the reference databases
Organism(s)
Raman spectroscopy IR spectroscopy
No. (%) identified
correctly
Misidentification
(no. of strains)
No. (%) identified
correctly
Misidentification
(no. of strains)
S. aureus 9 (100) 13 (100)
CNSa 25 (96.2) S. aureus (1) 17 (94.4) S. aureus (1)
E. coli 16 (97.3) E. cloacae (1) 12 (100)
E. cloacae 9 (81.8) E. aerogenes (2) 6 (100)
E. aerogenes 7 (77.8) E. cloacae (2) 6 (100)
P. aeruginosa 9 (100) 5 (100)
E. faecalis groupa 8 (100) 9 (100)
E. faecium groupa 8 (100) 9 (100)
Streptococcus spp.a 8 (88.9) E. faecalis (1) 9 (82) E. faecalis group (1)
Candida albicans 6 (85.7) C. kefyr (1) 7 (87.5) C. dubliniensis (1)
Candida dubliniensis 5 (100)
Candida glabrata 5 (100) 5 (100)
Candida kefyr 7 (100) 4 (100)
Candida krusei 7 (100) 4 (100)
Candida tropicalis 8 (100) 5 (83.3) C. albicans (1)
a In the different species groups, the following species were included (number of strains in Raman database/number in IR database): CNS, S. epidermidis (10/6), S.
schleiferi (3/2), S. saprophyticus (3/2), S. haemolyticus (3/2), S. capitis (3/2), S. lugdunensis (2/0), S. warneri (2/2), and S. hominis (0/2); Streptococcus spp., S. agalactiae
(1/0), S. oralis (2/3), S. salivarus (2/2), S. pneumoniae (1/2), S. pyogenes (3/3), and Streptococcus variant Gr. A (0/1); Enterococcus faecium group, E. faecium (6/5), E. hirae
(1/2), and E. durans (1/2); Enterococcus faecalis group (identified as such for IR analysis only), E. faecalis (6), E. casseliflavus (1), and E. gallinarum (2).
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yeast strains included in the databases, high identification ac-
curacy was achieved as well (Table 1).
Analysis of clinical samples. We collected 135 blood cul-
tures from 92 patients at the University Hospital Rotterdam
for analysis by the Raman method. Bacteria were isolated from
129 blood cultures and 6 were positive for yeast. Similarly, 138
blood cultures were examined from 121 patients of the Rudolf
Virchow Hospital; of these, 131 contained bacteria and 7 con-
tained yeast. These samples were analyzed by FT-IR spectros-
copy. For both the Raman and FT-IR tests, 17 strains were
excluded from the comparison because the phenotypic identi-
fication yielded a species not included in the database. In
addition, three samples containing mixed cultures with very
similar cell morphologies, such as E. coli and E. aerogenes, were
excluded from the comparison between Raman spectroscopy
and routine identification, as it was not obvious which species
was measured in the Raman experiments. However, in all
cases, the Raman identification corresponded to one of the
components in the mixed culture.
The results of the comparison between the vibrational spec-
troscopies and the phenotypic identifications are presented in
Table 2. Raman spectroscopy correctly identified 92.2% (106
of 115) of the microorganisms included in the comparison, and
98.3% (119 of 121) were accurately identified by IR spectros-
copy.
DISCUSSION
The work presented here was a feasibility study. However,
the results of this first prospective study illustrate the enor-
mous potential of vibrational spectroscopic methods for rapid
and accurate microbial identification. The fundamental
strength of this approach is emphasized by the fact that this
study was performed at two hospitals employing different spec-
troscopic methods, different sample-handling protocols, differ-
ent methods of signal analysis, and different prediction models
but yielding equally good results. Correct identification of 92.2
and 98.3% of the samples (by the Raman and IR methods,
respectively) was achieved for spectra that were available 6 to
8 h after signaling by an automated blood culture system.
For 106 of the remaining 115 samples, Raman spectroscopic
identification corresponded to the phenotypic identification of
the routine diagnostic test. Four of the nine misidentifications
can be explained. The two E. coli isolates identified as E.
aerogenes were collected from one patient only 5 h apart, mak-
ing it very likely that the strains were identical. A similar
situation occurred for two of the three E. cloacae isolates
identified by the Raman method as E. aerogenes. Two of the
FIG. 2. Sequential identification schemes used for the identifica-
tion of bacteria. (a) Sequential LDA model used for identification of
microorganisms on the basis of their Raman spectra. (b) Schematic
diagram of the hierarchical network used to identify bacteria on the
basis of their IR spectra. See the text for details.
TABLE 2. Comparison of phenotypic and vibrational spectroscopic identifications of patient samples included in the prospective studya
Organism(s)
Raman spectroscopy IR spectroscopy
No. (%) identified
correctly
Misidentification(s)
(no. of strains)
No. (%) identified
correctly
Misidentification
(no. of strains)
S. aureus 19 (100) 27 (96.4) S. aureus (1)
CNS 37 (97.4) Streptococcus sp. (1) 52 (98.1) CNS (1)
E. coli 22 (91.7) E. aerogenes (2) 12 (100)
E. cloacae 2 (40) E. aerogenes (3) 2 (100)
E. aerogenes 3 (100)
P. aeruginosa 5 (100) 1 (100)
E. faecalis group 3 (100) 6 (100)
E. faecium group 1 (100) 5 (100)
Streptococcus spp. 8 (72.7) E. faecalis (2), E. aerogens (1) 7 (100)
Candida albicans 6 (100) 5 (100)
Candida glabrata 1 (100)
Candida tropicalis 1 (100)
a For Raman spectroscopy, 115 samples were included, and for IR spectroscopy, 121 samples were included.
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three Streptococcus species that were misidentified (Streptococ-
cus mitis and S. anginosus) were not included in the reference
database. IR spectroscopy correctly identified 119 of 121 sam-
ples. Nearly perfect identification of the main contributors to
the bloodstream infections (staphylococci and E. coli) was ob-
tained by both methods. The perfect identification of the sam-
ples with Candida species 6 (Raman) to 8 (IR) h after a
positive signal was obtained from the automated blood culture
systems is particularly encouraging, as routine phenotypic
identification required an additional 48 h.
Although these results are very encouraging, much larger
databases of vibrational spectra of a wider range of microbial
genera and species, as well as a larger number of isolates per
species, must be established. It will then become possible to
recognize whether a new isolate belongs to a species repre-
sented in the database or not (i.e., is an unknown). The rela-
tively low number of isolates per species in the current refer-
ence database does not enable reliable outlier detection.
Extension of the reference spectral databases to include a
wider range of microorganisms (genera, species, and strains)
will also enable development of other targeted medical micro-
biological applications. Intraabdominal infections with Can-
dida species, for example, are associated with high mortality
rates (5). Rapid identification is important because some spe-
cies are intrinsically resistant to antifungal agents of the azole
group, which are usually the agents of first choice in treating
this kind of infections. We have previously shown that highly
accurate rapid identification (97%) of Candida species by vi-
brational spectroscopic methods is possible (10). A clinical
pilot study of prospective Candida species identification in
intraabdominal infections by Raman spectroscopy is under
way. Another potential application for spectroscopic tech-
niques that makes use of the fact that very little biomass is
needed is the identification of fastidious microorganisms, e.g.,
mycobacteria. Routinely used phenotypic identification meth-
ods can take between 2 and 8 weeks to be completed for these
slow-growing bacteria (16). However, rapid identification of
Mycobacterium species is becoming increasingly important be-
cause of their increased incidence over the last decade. Rapid
discrimination between Mycobacterium tuberculosis and M.
avium, currently the topic of an FT-IR spectroscopic study, is
of prime importance for effectively guiding the choice of anti-
biotic therapy, as the two life-threatening infections in immu-
nocompromised patients require different types of manage-
ment and therapy.
The signal collection times used in this study (25 min for
Raman spectroscopy and 18 min for FT-IR spectroscopy) limit
the sample throughput. However, with further optimization of
the instrumentation, a reduction in signal collection time to
only a few minutes is feasible. This will also facilitate the
analysis of mixed cultures by performing the identification on
more microcolonies selected on the basis of cell and colony
morphology. Apart from the clinical significance, a practical
reason for our choice to target blood infections first was that
they are nearly always due to a single pathogen. Development
of dedicated culture media, which will enhance the rate of
microcolony development, is expected to further shorten the
necessary cultivation time.
Apart from enabling rapid identification, vibrational spec-
troscopic techniques require virtually no sample handling or
consumables, which is in sharp contrast to other rapid identi-
fication techniques that are under development, such as mo-
lecular genetic approaches. This implies that vibrational spec-
troscopic techniques are well suited to automation, can be used
by nonexperts, and are relatively inexpensive to use. Moreover,
vibrational spectroscopy also offers possibilities for the devel-
opment of rapid drug susceptibility testing (12). We conclude
that Raman and FT-IR spectroscopies provide a novel answer
to the need for rapid microbial identification in a clinical di-
agnostic setting.
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